Mechanism of cancer cachexia: Progress on disentangling a complex problem

Progress in Palliative Care

Volumn 10, Issue 4, 2002, Pages 161-167

  Strasser, Florian ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; ANTIINFECTIVE AGENT; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CHOLECYSTOKININ; CORTICOSTEROID DERIVATIVE; CYTOKINE; FLUOXYMESTERONE; GESTAGEN; GHRELIN; GROWTH HORMONE; HYDROCORTISONE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NANDROLONE; NEUROPEPTIDE Y; NEUROTRANSMITTER; OXANDROLONE; RIMONABANT; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; STEROID HORMONE; TESTOSTERONE; THYROXINE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADVANCED CANCER; AUTOCRINE EFFECT; CACHEXIA; CALORIC INTAKE; CARCINOGENESIS; COMORBIDITY; CONTROLLED STUDY; DIET THERAPY; DRUG ACTIVITY; ENERGY BALANCE; FEMALE; FOOD INTAKE; HUMAN; HYPOGONADISM; MALE; MOUSE; MUSCLE ATROPHY; NEUROENDOCRINE DISEASE; NEUROPATHOLOGY; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; QUALITY OF LIFE; RAT; REVIEW; STARVATION; SYMPTOMATOLOGY; WEIGHT REDUCTION;

EID: 0036384846     PISSN: 09699260     EISSN: None     Source Type: Journal    
DOI: 10.1080/09699260.2002.11746631     Document Type: Review

References (55)

1. Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 1997;66:683-706.
2. Jatoi A Jr, Loprinzi CL. Current management of cancer-associated anorexia and weight loss. Oncology 2001;15:497-502.
3. Pasanisi F, Orban A, Scalfi L, et al. Predictors of survival in terminal-cancer patients with irreversible bowel obstruction receiving home parenteral nutrition. Nutrition 2001;17:581-4.
4. Argiles JM, Lopez-Soriano FJ. Catabolic proinflammatory cytokines. Curr Opin Clin Nutr Metab Care 1998;1:245-51.
5. Sliwa JA, Marciniak C. Physical rehabilitation of the cancer patient. Cancer Treat Res 1999;100:75-89
6. Al-Majid S, McCarthy DO. Cancer-induced fatigue and skeletal muscle wasting: the role of exercise. Biol Res Nurs 2001;2:186-97.
7. Williams B, Waters D, Parker K. Evaluation and treatment of weight loss in adults with HIV disease. Am Fam Physician 1999;60:843-54, 857-60.
8. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997;349:1050-3.
9. Argiles JM, Busquets S, Lopez-Soriano FJ. Metabolic interrelationships between liver and skeletal muscle in pathological states. Life Sci 2001;69:1345-61.
10. Meguid MM, Yang ZJ, Gleason JR. The gut-brain brain-gut axis in anorexia: toward an understanding of food intake regulation. Nutrition 1996;12:S57-62.
11. Strasser F, Bruera E. Update on Anorexia/Cachexia. Hemat Oncol Clin N Am 2002, in press.
12. Bozzetti F, Gavazzi C, Ferrari P, et al. Effect of total parenteral nutrition on the protein kinetics of patients with cancer cachexia. Tamori 2000;86:408-11.
13. Barber MD, Fearon KC, McMillan DC, et al. Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients. Am J Physiol Endocrinol Metab 2000;279:E707-14.
14. Schwartz MW, Woods SC, Porte D Jr, et al. Central nervous system control of food intake. Nature 2000;404:661-71.
15. Konsman JP, Dantzer R. How the immune and nervous systems interact during disease-associated anorexia. Nutrition 2001;17:664-8.
16. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-8.
17. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-70.
18. Gaillard RC, Spinedi E, Chautard T, Pralong FP. Cytokines, leptin, and the hypothalamo-pituitary-adrenal axis. Ann N Y Acad Sci 2000;917:647-57.
19. Mantovani G, Maccio A, Madeddu C, et al. Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites. J Mol Med 2001;79:406-14.
20. Jatoi A, Loprinzi CL, Sloan JA, et al. Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Cancer 2001;92:629-33.
21. Bing C, Taylor S, Tisdale MJ, et al. Cachexia in MAC16 adenocarcinoma: suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y. J Neurochem 2001;79:1004-12.
22. Di Matzo V, Goparaju SK, Wang L, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001;410:822-5.
23. Wisse BE, Frayo RS, Schwartz MW, et al. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology 2001;142:3292-301.
24. Bruera E, Chadwick S, Fox R, et al. Study of cardiovascular autonomic insufficiency in advanced cancer patients. Cancer Treat Rep 1986;70:1383-7.
25. Bruera E, Catz Z, Hooper R, et al. Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction. J Pain Symptom Manage 1987;2:19-21.
26. Mathias CJ. Autonomic disorders and their recognition. N Engl J Med 1997;336:721-4.
27. Jenkins RC, Ross RJ. Acquired growth hormone resistance in catabolic states. Baillieres Clin Endocrinol Metab 1996;10:411-9.
28. Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999;341:785-92.
29. Fang CH, Li BG, Sun X, et al. Insulin-like growth factor I reduces ubiquitin and ubiquitin-conjugating enzyme gene expression but does not inhibit muscle proteolysis in septic rats. Endocrinology 2000;141:2743-51.
30. Simons JP, Schols AM, Buurman WA, et al. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond) 1999;97:215-23.
31. Helle SI, Geisler J, Anker GB, et al. Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer. Br J Cancer 2001;85:147-51.
32. Anker SD, Volterrani M, Pflaum CD, et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol 2001;38:443-52.
33. Schambelan M, Mulligan K, Grunfeld C, et al. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med 1996;125: 873-82.
34. Osterziel KJ, Strohm O, Schuler J, et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998;351:1233-7.
35. Papadakis MA, Grady D, Black D, et al. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996;124:708-16.
36. Burdet L, de Muralt B, Schutz Y, et al. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med 1997;156: 1800-6.
37. Morley JE. Anorexia, body composition, and ageing. Curr Opin Clin Nutr Metab Care 2001;4:9-13.
38. Lobo RA. Androgens in postmenopausal women: production, possible role, and replacement options. Obstet Gynecol Surv 2001;56:361-76.
39. Grinspoon S, Corcoran C, Lee K, et al. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab 1996;81:4051-8.
40. Grinspoon S, Corcoran C, Miller K, et al. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab 1997;82:1332-7.
41. Grinspoon S, et al. Sustained anabolic effects of long-term androgen administration in men with AIDS wasting. Clin Infect Dis 1999;28: 634-6.
42. Strawford A, et al. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. JAMA 1999;281:1282-90.
43. Wagner GJ, Rabkin JG. Testosterone therapy for clinical symptoms of hypogonadism in eugonadal men with AIDS. Int J STD AIDS 1998;9:41-4.
44. Blackman WR, Weintraub BD, Rosen SW, et al. Comparison of the effects of lung cancer, benign lung disease, and normal aging on pituitary-gonadal function in men. J Clin Endocrinol Metab 1988;66:88-95.
45. Chlebowski RT, Heber D. Hypogonadism in male patients with metastatic cancer prior to chemotherapy. Cancer Res 1982;42:2495-8.
46. Todd BD. Pancreatic carcinoma and low serum testosterone; a correlation secondary to cancer cachexia? Eur J Surg Oncol 1988;14:199-202.
47. Chlebowski RT, et al. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer. Cancer 1986;58:183-6.
48. Darnton SJ, Zgainski B, Grenier I, Allister K, Hiller L, McManus KG et al. The use of an anabolic steroid (nandrolone decanoate) to improve nutritional status after esophageal resection for carcinoma. Dis Esophagus 1999;12: 283-8.
49. Loprinzi CL, et al. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 1999;17:3299-306.
50. Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000;16:1009-12.
51. Negri DR, Mezzanzanica D, Sacco S, et al. Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours. Cytokine 2001;15:27-38.
52. Zhang Y, Pilon G, Marette A, et al. Cytokines and endotoxin induce cytokine receptors in skeletal muscle. Am J Physiol Endocrinol Metab 2000;279:E196-205.
53. Cabal-Manzano R, Bhargava P, Torres-Duarte A, et al. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss. Br J Cancer 2001;84:1599-601.
54. Lorite MJ, Smith HJ, Arnold JA, et al. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). Br J Cancer 2001;85:297-302.
55. Lazarus DD, Destree AT, Mazzola LM (1999). A new model of cancer cachexia: contribution of the ubiquitin-proteasome pathway. Am J Physiol 1999;277:E332-41.